266 related articles for article (PubMed ID: 33297848)
1.
Matin MM; Uzzaman M; Chowdhury SA; Bhuiyan MMH
J Biomol Struct Dyn; 2022 May; 40(8):3668-3680. PubMed ID: 33297848
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, antimicrobial, SAR, PASS, molecular docking, molecular dynamics and pharmacokinetics studies of 5'-
Munia NS; Hosen MA; Azzam KMA; Al-Ghorbani M; Baashen M; Hossain MK; Ali F; Mahmud S; Shimu MSS; Almalki FA; Hadda TB; Laaroussi H; Naimi S; Kawsar SMA
Nucleosides Nucleotides Nucleic Acids; 2022; 41(10):1036-1083. PubMed ID: 35797068
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, antimicrobial, molecular docking and molecular dynamics studies of lauroyl thymidine analogs against SARS-CoV-2: POM study and identification of the pharmacophore sites.
Anowar Hosen M; Sultana Munia N; Al-Ghorbani M; Baashen M; Almalki FA; Ben Hadda T; Ali F; Mahmud S; Abu Saleh M; Laaroussi H; Kawsar SMA
Bioorg Chem; 2022 Aug; 125():105850. PubMed ID: 35533581
[TBL] [Abstract][Full Text] [Related]
4.
Hosen MA; Qais FA; Chtita S; Rahman IA; Almehdi AM; Ali F; Almalki FA; Hadda TB; Laaroussi H; Kawsar SMA
Nucleosides Nucleotides Nucleic Acids; 2023; 42(11):877-918. PubMed ID: 37235455
[TBL] [Abstract][Full Text] [Related]
5. Methyl β-D-galactopyranoside esters as potential inhibitors for SARS-CoV-2 protease enzyme: synthesis, antimicrobial, PASS, molecular docking, molecular dynamics simulations and quantum computations.
Amin MR; Yasmin F; Dey S; Mahmud S; Saleh MA; Emran TB; Hasan I; Rajia S; Ogawa Y; Fujii Y; Yamada M; Ozeki Y; Kawsar SMA
Glycoconj J; 2022 Apr; 39(2):261-290. PubMed ID: 35037163
[TBL] [Abstract][Full Text] [Related]
6. Novel Galactopyranoside Esters: Synthesis, Mechanism, In Vitro Antimicrobial Evaluation and Molecular Docking Studies.
Matin P; Hanee U; Alam MS; Jeong JE; Matin MM; Rahman MR; Mahmud S; Alshahrani MM; Kim B
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807371
[TBL] [Abstract][Full Text] [Related]
7. Uridine Derivatives: Synthesis, Biological Evaluation, and In Silico Studies as Antimicrobial and Anticancer Agents.
Munia NS; Alanazi MM; El Bakri Y; Alanazi AS; Mukhrish YE; Hasan I; Kawsar SMA
Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374310
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, Antimicrobial, Anticancer, PASS, Molecular Docking, Molecular Dynamic Simulations & Pharmacokinetic Predictions of Some Methyl β-D-Galactopyranoside Analogs.
Amin MR; Yasmin F; Hosen MA; Dey S; Mahmud S; Saleh MA; Emran TB; Hasan I; Fujii Y; Yamada M; Ozeki Y; Kawsar SMA
Molecules; 2021 Nov; 26(22):. PubMed ID: 34834107
[TBL] [Abstract][Full Text] [Related]
9. Molecular docking, binding mode analysis, molecular dynamics, and prediction of ADMET/toxicity properties of selective potential antiviral agents against SARS-CoV-2 main protease: an effort toward drug repurposing to combat COVID-19.
Rai H; Barik A; Singh YP; Suresh A; Singh L; Singh G; Nayak UY; Dubey VK; Modi G
Mol Divers; 2021 Aug; 25(3):1905-1927. PubMed ID: 33582935
[TBL] [Abstract][Full Text] [Related]
10. Virtual screening, ADMET profiling, PASS prediction, and bioactivity studies of potential inhibitory roles of alkaloids, phytosterols, and flavonoids against COVID-19 main protease (M
Abdul-Hammed M; Adedotun IO; Olajide M; Irabor CO; Afolabi TI; Gbadebo IO; Rhyman L; Ramasami P
Nat Prod Res; 2022 Jun; 36(12):3110-3116. PubMed ID: 34107799
[TBL] [Abstract][Full Text] [Related]
11. Molecular Docking and Dynamics Investigations for Identifying Potential Inhibitors of the 3-Chymotrypsin-like Protease of SARS-CoV-2: Repurposing of Approved Pyrimidonic Pharmaceuticals for COVID-19 Treatment.
Elzupir AO
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946540
[TBL] [Abstract][Full Text] [Related]
12. Computational study for identifying promising therapeutic agents of hydroxychloroquine analogues against SARS-CoV-2.
Prasanth DSNBK; Murahari M; Chandramohan V; Guntupalli C; Atmakuri LR
J Biomol Struct Dyn; 2022; 40(22):11822-11836. PubMed ID: 34396938
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a "Cocktail" of Potential SARS-COV-2 Main Protease Inhibitors through Virtual Screening of Known Chemical Components of Vitex negundo L. ("Lagundi").
Cayona R; Creencia E
Med Chem; 2022; 18(3):364-381. PubMed ID: 34148541
[TBL] [Abstract][Full Text] [Related]
14. In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors.
Ibrahim MAA; Abdelrahman AHM; Allemailem KS; Almatroudi A; Moustafa MF; Hegazy MF
Protein J; 2021 Jun; 40(3):296-309. PubMed ID: 33387249
[TBL] [Abstract][Full Text] [Related]
15.
Rudrapal M; Issahaku AR; Agoni C; Bendale AR; Nagar A; Soliman MES; Lokwani D
J Biomol Struct Dyn; 2022; 40(20):10437-10453. PubMed ID: 34182889
[TBL] [Abstract][Full Text] [Related]
16. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
[TBL] [Abstract][Full Text] [Related]
17. Computational study on the affinity of potential drugs to SARS-CoV-2 main protease.
Martín V; Sanz-Novo M; León I; Redondo P; Largo A; Barrientos C
J Phys Condens Matter; 2022 May; 34(29):. PubMed ID: 35504274
[TBL] [Abstract][Full Text] [Related]
18. The inhibitory effect of some natural bioactive compounds against SARS-CoV-2 main protease: insights from molecular docking analysis and molecular dynamic simulation.
Abdelrheem DA; Ahmed SA; Abd El-Mageed HR; Mohamed HS; Rahman AA; Elsayed KNM; Ahmed SA
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2020; 55(11):1373-1386. PubMed ID: 32998618
[TBL] [Abstract][Full Text] [Related]
19. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
Kumar Y; Singh H; Patel CN
J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulants as Potential SARS-CoV-2 M
Abo Elmaaty A; Eldehna WM; Khattab M; Kutkat O; Alnajjar R; El-Taweel AN; Al-Rashood ST; Abourehab MAS; Binjubair FA; Saleh MA; Belal A; Al-Karmalawy AA
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
